BVS NASDAQ
Bioventus Inc.
1W: -4.9%
1M: -8.6%
3M: +11.5%
YTD: +82.1%
1Y: +95.7%
3Y: +334.8%
5Y: -10.4%
$13.13
-0.32 (-2.38%)
Weekly Expected Move ±4.9%
$12
$12
$13
$14
$14
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
17 relationships17
As Filer
counterparties named
0
As Counterparty
mentioned by others
4
Rel. Types
2021-03-31
Earliest Filing
2025-01-03
Latest Filing
partner: 7
target: 5
acquirer: 3
investor: 2
Counterparties (Filed by BVS)
17 relationshipsCompanies named in BVS's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Bioness Medical, Inc. | — | acquirer | Acquired Rehab Neuromodulation business assets and shares from Bioventus LLC and subsidiaries | 2025-01-03 | View |
| Bioness Neuromodulation Ltd. | — | target | Wholly-owned subsidiary of Bioness sold to Bioness Medical, Inc. | 2025-01-03 | View |
| Bioness | — | partner | Parent company of Bioness Neuromodulation Ltd. and seller in the transaction | 2025-01-03 | View |
| Bioventus Cooperatief, U.A. | BVS | partner | Dutch subsidiary of Bioventus Inc. and seller in the transaction | 2025-01-03 | View |
| Bioventus LLC | BVS | partner | Delaware subsidiary of Bioventus Inc. and seller in the transaction | 2025-01-03 | View |
| Rehab Acquisition Corporation, III | — | acquirer | Acquired Bioness Neuromodulation Ltd. and Rehab Products business assets from Bioventus subsidiaries. | 2024-10-04 | View |
| LifeNet Health | — | acquirer | Acquired assets related to TheraSkin and TheraGenesis products from Bioventus subsidiaries. | 2023-05-16 | View |
| Elron Ventures Ltd | — | investor | Securityholder Representative involved in settlement agreement regarding Option Agreement | 2023-03-03 | View |
| CartiHeal (2009) Ltd | — | target | Company whose shares were transferred to a trustee as part of the settlement | 2023-03-03 | View |
| CartiHeal (2009) Ltd. | — | target | Target company acquired by Bioventus LLC for approximately $315 million. | 2022-07-12 | View |
| CartiHeal (2009) Ltd. | — | target | Target of acquisition for approximately $315 million upfront consideration | 2022-06-22 | View |
| Elron Ventures Ltd. | — | investor | Shareholder Representative in the Option and Equity Purchase Agreement | 2022-06-22 | View |
| Bioness Inc. | — | target | Target of the statutory merger acquired by Bioventus Inc. | 2021-03-31 | View |
| Perseus Intermediate, Inc. | — | partner | Wholly-owned subsidiary of Bioventus LLC and parent of the merger subsidiary. | 2021-03-31 | View |
| Perseus Merger Sub, Inc. | — | partner | Wholly-owned subsidiary of Perseus Intermediate used to acquire Bioness. | 2021-03-31 | View |
| Alfred E. Mann Living Trust | — | partner | Stockholder representative party to the merger agreement. | 2021-03-31 | View |
| Mann Group, LLC | MNKD | partner | Delaware limited liability company party to the merger agreement. | 2021-03-31 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-08-05 | Earnings Release; Other Events; Exhibits | View | |
| 2026-06-04 | Shareholder Vote | View | |
| 2026-05-21 | Regulation FD | View | |
| 2026-05-06 | Earnings Release; Exhibits | View | |
| 2026-03-05 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-11-17 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-11-04 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-08-06 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-08-04 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Financial Stateme | Agreement | View |
| 2025-07-31 | Other Events; Financial Statements and Exhibits | View | |
| 2025-06-04 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-05-06 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-03-11 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-01-03 | Completion of Acquisition or Disposition of Assets; Other Events; Financial Statements and Exhibits | Acquisition | View |
| 2024-11-05 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-10-04 | Entry into Material Definitive Agreement; Other Events; Financial Statements and Exhibits | Agreement | View |
| 2024-08-06 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-07-19 | Other Events | View | |
| 2024-06-21 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2024-06-17 | Material Modification to Rights of Security Holders; Amendments to Articles of Incorporation or Byla | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR